Edesa Biotech, Inc. (EDSA)
Edesa Biotech Inc. (NASDAQ: EDSA) joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study.
Canadian biopharma Edesa Biotech Inc (NASDAQ: EDSA) is seeing its shares surge higher Monday after it announced regulatory approval to begin a late-stage study of its investigational asset for...
Edesa Biotech received go ahead from FDA to initiate its phase 2b study using EB01 to treat patients with chronic contact dermatitis.
Edesa Biotech (EDSA) stock is flying higher on Thursday after getting approval from the U.S. Food and Drug Administration (FDA).
Edesa Biotech Inc., shares were trading higher Thursday after the company received Food and Drug Administration approval to proceed with its U.S.